Italy v Council (Siège de l'Agence europeenne des medicaments) (annulment - Law governing the institutions - European Medicines Agency - Judgment) [2022] EUECJ C-59/18 (14 July 2022)

Italy v Council (Siège de l'Agence europeenne des medicaments) (annulment - Law governing the institutions - European Medicines Agency - Judgment) [2022] EUECJ C-59/18 (14 July 2022)

The Court held that the contested decision designating Amsterdam as the new seat of the European Medicines Agency was adopted by the Representatives of the Governments of the Member States, not by the Council or any EU institution, body, office, or agency. As such, it is not subject to judicial review under Article...

Source-derived case information.

Citation
[2022] EUECJ C-59/18
Parties
Applicant: Italian Republic; Applicant: Comune di Milano (Municipality of Milan, Italy); Respondent: Council of the European Union; Intervener (supporting Council): Kingdom of the Netherlands; Intervener (supporting Council): European Commission; Intervener (supporting Comune Di Milano): Regione Lombardia (Region of Lombardy, Italy)
Jurisdiction
European Union
Procedural Posture
Joined Applications for Annulment (c 59/18 and C 182/18) / Final Judgment
Outcome
Actions dismissed as inadmissible
Legal Topics
Competence to Determine Seat of EU Agencies, Judicial Review Under Article 263 TFEU, Attribution of Acts to EU Institutions or Member States, Interpretation of Article 341 TFEU, Binding Legal Effects of Intergovernmental Acts
European Union Law Administrative Law Constitutional Law Competence to Determine Seat of EU Agencies Judicial Review Under Article 263 TFEU Attribution of Acts to EU Institutions or Member States Interpretation of Article 341 TFEU Binding Legal Effects of Intergovernmental Acts

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Downloadable case file Legal principles 3 Authorities cited 18 Party arguments 2
Sign in to unlock

Parties

Italian Republic

Applicant

Comune di Milano (Municipality of Milan, Italy)

Applicant

Council of the European Union

Respondent

Kingdom of the Netherlands

Intervener (supporting Council)

European Commission

Intervener (supporting Council)

Regione Lombardia (Region of Lombardy, Italy)

Intervener (supporting Comune Di Milano)

Procedural Posture

Joined Applications for Annulment (c 59/18 and C 182/18) / Final Judgment

  1. 1 Whether the decision designating Amsterdam as the new seat of the European Medicines Agency is attributable to the Council or to the Member States acting collectively
  2. 2 Whether such a decision is subject to judicial review under Article 263 TFEU
  3. 3 Whether Article 341 TFEU applies to the seat of EU agencies

Ratio Decidendi

The Court held that the contested decision designating Amsterdam as the new seat of the European Medicines Agency was adopted by the Representatives of the Governments of the Member States, not by the Council or any EU institution, body, office, or agency. As such, it is not subject to judicial review under Article 263 TFEU. Furthermore, Article 341 TFEU applies only to the seat of the institutions of the Union, not to agencies established by secondary legislation. The competence to determine the seat of such agencies lies with the EU legislature, which must act in accordance with the relevant legislative procedures. The contested decision, being an act of the Member States outside the...

Court Disposition

Actions dismissed as inadmissible

Orders

  • The actions brought by the Italian Republic and the Comune di Milano are dismissed as inadmissible.